During the acute COPD exacerbation, which antibiotic was used initially?

• A. Clarithromycin
• B. Amoxicillin
• C. Doxycycline
• D. Ciprofloxacin

Answer: (C)

In acute COPD exacerbations treated as outpatient, the aim is to cover the bacteria that most commonly trigger these flares: Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, plus the atypicals. Doxycycline fits well because it reliably targets these organisms, including many strains of H. influenzae and M. catarrhalis, and it also covers atypical pathogens such as Mycoplasma and Chlamydophila. It’s easy to take (oral dosing), generally well tolerated, and has relatively few drug interactions. This makes it a practical first-line option for mild to moderate exacerbations.

Amoxicillin can be effective, but some H. influenzae strains produce beta-lactamase and aren’t fully covered unless you use amoxicillin-clavulanate. A macrolide like clarithromycin also covers similar pathogens but comes with more potential drug interactions and resistance considerations in some settings. Ciprofloxacin provides strong Gram-negative coverage and is useful when there’s a concern for Pseudomonas or in severe cases, but it isn’t preferred as the initial choice for a mild-to-moderate outpatient exacerbation due to safety concerns and resistance patterns.

So, starting with doxycycline aligns with typical outpatient management goals for a mild-to-moderate COPD flare, balancing effective coverage with safety and practicality.